The Ensign Group (NASDAQ:ENSG) Stock Rating Upgraded by Wall Street Zen

The Ensign Group (NASDAQ:ENSG) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday, Wall Street Zen reports.

Other equities research analysts have also issued reports about the stock. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of The Ensign Group in a report on Friday, September 11th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $228.00 price objective on shares of The Ensign Group in a report on Tuesday, July 28th. Finally, Truist Financial upped their price objective on shares of The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a research report on Thursday, July 30th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, The Ensign Group has a consensus rating of “Moderate Buy” and an average target price of $216.25.

The Ensign Group Stock Performance

The Ensign Group stock opened at $171.78 on Friday. The stock’s 50 day moving average price is $176.65 and its 200 day moving average price is $177.49. The firm has a market capitalization of $10.01 billion, a PE ratio of 26.92, a price-to-earnings-growth ratio of 1.63 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The Ensign Group has a one year low of $141.58 and a one year high of $218.00.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings data on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.12. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The Ensign Group’s revenue for the quarter was up 16.7% on a year-over-year basis. During the same quarter last year, the company earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. As a group, sell-side analysts expect that The Ensign Group will post 7.04 EPS for the current fiscal year.

Insider Activity

In related news, Director John Agwunobi sold 392 shares of the company’s stock in a transaction on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the sale, the director directly owned 9,503 shares of the company’s stock, valued at $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.00% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ENSG. Transamerica Financial Advisors LLC bought a new stake in shares of The Ensign Group in the 2nd quarter worth about $26,000. Monetary Solutions Ltd bought a new position in shares of The Ensign Group during the fourth quarter worth about $30,000. Bayban acquired a new position in The Ensign Group in the fourth quarter worth about $31,000. Caitlin John LLC acquired a new position in The Ensign Group in the second quarter worth about $31,000. Finally, Cedar Mountain Advisors LLC bought a new stake in The Ensign Group in the first quarter valued at about $32,000. 96.12% of the stock is owned by institutional investors and hedge funds.

The Ensign Group News Summary

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Ensign acquired skilled nursing and senior living operations in Florida, Colorado, and Washington, adding roughly 2,000 skilled nursing beds and expanding its portfolio to 418 healthcare operations across 18 states. The move strengthens its geographic footprint and could provide additional revenue and earnings growth if the facilities are integrated successfully. The Ensign Group Expands Portfolio with Acquisitions in Washington, Florida and Colorado
• Positive Sentiment: The Florida expansion gives Ensign an entry into a large healthcare market, while the Washington and Colorado transactions deepen its presence in existing regions. Several facilities are tied to long-term triple-net leases, and Ensign also acquired real estate assets for five facilities through its captive REIT. The Ensign Group Announces Expansion Into Florida
• Positive Sentiment: Recent operating momentum remains favorable: quarterly revenue rose about 17% year over year to approximately $1.44 billion, and earnings per share exceeded consensus estimates. Zacks also highlighted ENSG as a strong growth stock, reinforcing the view that acquisitions and organic performance can support future results. Here’s Why Ensign Group is a Strong Growth Stock
• Neutral Sentiment: The rapid multi-state expansion could increase integration, staffing, and financial obligations, particularly because Ensign often targets facilities requiring operational improvement. Investors will look for details on acquisition costs, occupancy, margins, and the pace of earnings contribution.
• Negative Sentiment: Rosen Law Firm and Kaplan Fox announced investigations into potential securities-law violations, alleging that Ensign may have issued materially misleading business information. The announcements do not establish wrongdoing, but they create legal, reputational, and potential financial risks for shareholders. Rosen Law Firm Securities Class Action Investigation

The Ensign Group Company Profile

The Ensign Group, Inc (NASDAQ: ENSG) is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.

The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.